NHPA report compares performance of Queensland hospitals on cancer surgeries

NewsGuard 100/100 Score

Cancer Council Queensland has welcomed the first release of cancer surgery waiting times from the National Hospital Performance Authority.

According to the NHPA report, most Queensland patients awaiting surgery for malignant bowel, breast, and lung cancers receive surgery within recommended timeframes. 

Spokesperson for Cancer Council Queensland, Katie Clift, said the report was reassuring.

“This report provides a good hospital-by-hospital comparison of performance on cancer surgeries,” Ms Clift said.

“Encouragingly, most cancer patients who need surgery for breast, bowel or lung cancer are being treated within recommended timeframes.”

“This is good news for cancer patients and a credit to the health professionals in Queensland’s public hospitals.”

Of concern to Cancer Council Queensland, the report also found that some hospitals did not perform as well as others.

“This comparison of hospital performance highlights the importance of integrated cancer treatment services across Queensland’s Hospital and Health Services,” she said.

“Where some hospitals perform less well, enhanced cooperation between hospitals would help to ensure all hospitals have the capacity to treat patients within recommended timeframes.

“In interpreting the findings of this report, it is important to note that Queensland’s major hospitals play a pivotal role in providing specialised treatment for cancer patients and in treating many regional patients, who are commonly referred to superspeciality hospitals such as the Princess Alexandra.”

The number of new cancer diagnoses in Queensland is forecast to increase by 48 per cent to 2021, at a rate of about 4.4 per cent per year, more than double the rate of population growth, a trend Ms Clift said would place additional demand on major hospitals.

“With an ageing and increasing population, greater numbers of Queenslanders will be diagnosed with cancer each year into the future,” Ms Clift said.

“Investment in cancer treatment services will be vital in meeting demand and ensuring patients are treated within recommended timeframes.

“Any delay in cancer treatment can have serious adverse effects on a patient’s prospects for survival and can exacerbate the psychological distress often experienced by patients. 

“The opening of new regional cancer centres over the next 12 months will make a significant difference to cancer patients across the state, reducing waiting times at hospitals such as the Princess Alexandra and allowing many regional patients to be treated closer to home.”

According to Cancer Council Queensland, investment in health prevention would be critical to underpinning service standards and hospital performance.

“Although nearly 24,000 Queenslanders are diagnosed with cancer each year, research has found a third of cancers could be preventable through healthy living,” Ms Clift said. 

“Public funding for preventive health is therefore critical at the Hospital and Health Service level and must be integrated across the health system.

“If we can improve the health of all Queenslanders through public funding for prevention and awareness, future demand on the health system will be more manageable.

“Preventive health programs are one of the best ways to support a healthy and active population to reduce cancer incidence and ensure all patients can be treated within clinically recommended timeframes,” she said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases